ProfileGDS4814 / ILMN_1735552
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 95% 95% 95% 95% 95% 95% 95% 95% 96% 95% 95% 96% 95% 95% 94% 94% 95% 95% 96% 95% 95% 96% 95% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)943.47195
GSM780708Untreated after 4 days (C2_1)818.24295
GSM780709Untreated after 4 days (C3_1)825.83895
GSM780719Untreated after 4 days (C1_2)882.08595
GSM780720Untreated after 4 days (C2_2)859.46595
GSM780721Untreated after 4 days (C3_2)832.50895
GSM780710Trastuzumab treated after 4 days (T1_1)884.41595
GSM780711Trastuzumab treated after 4 days (T2_1)903.6895
GSM780712Trastuzumab treated after 4 days (T3_1)1134.5696
GSM780722Trastuzumab treated after 4 days (T1_2)856.01595
GSM780723Trastuzumab treated after 4 days (T2_2)953.47295
GSM780724Trastuzumab treated after 4 days (T3_2)1003.8296
GSM780713Pertuzumab treated after 4 days (P1_1)904.39295
GSM780714Pertuzumab treated after 4 days (P2_1)831.12695
GSM780715Pertuzumab treated after 4 days (P3_1)799.79394
GSM780725Pertuzumab treated after 4 days (P1_2)788.53294
GSM780726Pertuzumab treated after 4 days (P2_2)822.12495
GSM780727Pertuzumab treated after 4 days (P3_2)820.21495
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)1042.5196
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)951.81495
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)913.74795
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)1026.2396
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)957.48895